Flavonoids

Flavonoids has been studied in 177 papers since 2012: 46 observational studies in people, 3 in animals, 4 in cells, 120 reviews; 72 in the past year. The newest story, Oct 4, 2026: “Dietary flavonoids link to lower mortality across CKM stages”.

Intervention

177 papers study it109 findingsUpdated

MeSH

Research on it is growing 34% faster than aging research as a whole: 270 papers in the latest year counted

More supplements

6 new papers in 30 daysSee all 176 papers on flavonoids

At a glance

Higher flavonoid intake is linked with lower mortality and frailty in human cohorts, with independent labs reporting these associations. A cohort of adults without baseline frailty shows no clear frailty link. Reviews describe cognitive benefits in humans and, in adults with sarcopenia, mixed muscle-strength results.

109 findings in 68 papers from 2015 to 2026, 6 of them since June 2026

Independent labs found the same change in people. 35 independent labs in 15 countries.

“The results showed that the effect of flavonoids on changes in IGF1 and IGFBP-3 was not statistically significant.”
A Systematic Review and Meta-Analysis on the Effect of Flavonoids on Insulin-like Growth Factor and Insulin-like Growth Factor Binding Protein and Incidence of Breast CancerCurrent medicinal chemistry2022doi:10.2174/0929867329666220801164740

4 of its findings point the other way.

Humans: replicated by independent labs. Cells, worms or flies and mice: a single group.
  • 35 independent labs in 15 countries
  • 4 findings against
  • Funders: National Institutes of Health and others
  • Humans46
  • Animals2
  • Model organisms1
  • Cells4
  • In silico3

What did studies of flavonoids find?

52

Studies of flavonoids measured 52 outcomes, among them oxidative stress and ROS signaling, inflammation and cognitive function.

Oxidative stress and ROS signaling

downin reviews6downin yeast cells1

7 studies
  1. Flavonoids decrease oxidative stress and ROS signaling.

    “They mitigate oxidative stress, enhance mitochondrial function, regulate autophagy, and modulate immune responses, offering potential therapeutic benefits against chronic diseases.”

    Review

    Recent Advances in Flavonoids and Chronic Disease: Mechanisms, Therapeutic Applications, and Future Directions

    Current medicinal chemistry

  2. Flavonoids decrease oxidative stress and ROS signaling (liposomes) (>60%).

    “liposomes improved cell viability (40-50%) and reduced oxidative stress (>60%).”

    Reviewliposomes

    Nanocarriers for lung health: ameliorating inflammation and cell aging using flavonoid-based nano nutrients

    Immunopharmacology and immunotoxicology

  3. Flavonoids decrease oxidative stress and ROS signaling (CVD review).

    “reducing oxidative stress by decreasing inducible nitric oxide synthase (iNOS) and reactive oxygen species (ROS) activity while enhancing endothelial nitric oxide synthase (eNOS) functionality”

    ReviewCVD review

    Flavonoids and Their Influence on the Gut Microbiome: Implications for Cardiovascular Health

    Nutrition bulletin

  4. Flavonoids inhibit oxidative stress and ROS signaling.

    “exert anti-inflammatory, anti-oxidative stress, and anti-aging effects in a large number of in vitro models and in vivo experiments”

    Review

    Research Progress of Flavonoids Regulating Endothelial Function

    Pharmaceuticals (Basel, Switzerland)

  5. Flavonoids decrease oxidative stress and ROS signaling.

    “Flavonoids can inhibit the expression and secretion of inflammatory factors in brain tissue, reduce the damage caused by oxidative stress”

    Reviewbrain

    Targeting gut-brain axis by dietary flavonoids ameliorate aging-related cognition decline: Evidences and mechanisms

    Critical reviews in food science and nutrition

  6. Flavonoids decrease oxidative stress and ROS signaling.

    “Furthermore, many dietary flavonoids have been shown to reduce oxidative stress and neuroinflammation”

    Review

    Dietary Flavonoids and Adult Neurogenesis: Potential Implications for Brain Aging

    Current neuropharmacology

  7. Flavonoids protect against oxidative stress and ROS signaling in yeast cells (acetic acid-induced oxidative stress).

    “Some natural quercetin analogs, including morin, kaempferol, aromadendrin, and steppogenin, protected yeast cells against oxidative stress induced by acetic acid”

    Cellsacetic acid-induced oxidative stress

    Model yeast as a versatile tool to examine the antioxidant and anti-ageing potential of flavonoids, extracted from medicinal plants

    Frontiers in pharmacology

More on Oxidative stress and ROS signaling

Inflammation

downin reviews7

7 studies
  1. Flavonoids decrease inflammation.

    “attenuate astrocyte-mediated neuroinflammation by suppressing NF-κB, MAPK, TLR, and NLRP3 inflammasome signaling”

    Reviewastrocyte

    Targeting Reactive Astrocytes with Flavonoids to Alleviate Neuroinflammation and Promote Synaptic Function

    Molecular neurobiology

  2. Flavonoids decrease inflammation (CVD review).

    “reduces inflammation mediated by lipopolysaccharide (LPS), and protects against heart failure, ischaemia, and atherosclerosis.”

    ReviewCVD review

    Flavonoids and Their Influence on the Gut Microbiome: Implications for Cardiovascular Health

    Nutrition bulletin

  3. Flavonoids decrease inflammation.

    “Flavonoids, a class of natural bioactive compounds abundantly found in plants, exhibit diverse pharmacological effects, including antioxidant, anti-inflammatory, and anti-osteoporosis activities.”

    Review

    Advancements in research on the anti-aging effects and mechanisms of flavonoids in natural products

    Frontiers in medicine

  4. Flavonoids inhibit inflammation.

    “exert anti-inflammatory, anti-oxidative stress, and anti-aging effects in a large number of in vitro models and in vivo experiments”

    Review

    Research Progress of Flavonoids Regulating Endothelial Function

    Pharmaceuticals (Basel, Switzerland)

  5. Flavonoids inhibit inflammation in brain tissue.

    “Flavonoids can inhibit the expression and secretion of inflammatory factors in brain tissue”

    Reviewin brain tissuebrain

    Targeting gut-brain axis by dietary flavonoids ameliorate aging-related cognition decline: Evidences and mechanisms

    Critical reviews in food science and nutrition

  6. Flavonoids decrease inflammation in vitro and animal models of focal ischemic stroke, AD, and PD.

    “these molecules reduce the activated neuroglia and several proinflammatory cytokines”

    Reviewin vitro and animal models of focal ischemic stroke, AD, and PD

    Anti-Inflammatory Effects of Flavonoids in Common Neurological Disorders Associated with Aging

    International journal of molecular sciences

  7. Flavonoids decrease inflammation.

    “Furthermore, many dietary flavonoids have been shown to reduce oxidative stress and neuroinflammation”

    Review

    Dietary Flavonoids and Adult Neurogenesis: Potential Implications for Brain Aging

    Current neuropharmacology

More on Inflammation

Cognitive function

upin humans3upin reviews1

4 studies
  1. Flavonoids improve cognitive function in humans.

    “Several studies have reported the beneficial role of flavonoids in improving memory, learning, and cognition in clinical settings.”

    Review

    A critical appraisal of geroprotective activities of flavonoids in terms of their bio-accessibility and polypharmacology

    Neurochemistry international

  2. Flavonoids improve cognitive function in humans (consumption of foods rich in flavonoids).

    “Randomized clinical trials have also shown that the improvement of cognitive functions resulting from the consumption of foods rich in flavonoids is independent of age and health conditions.”

    Reviewconsumption of foods rich in flavonoids

    Polyphenols and Their Impact on the Prevention of Neurodegenerative Diseases and Development

    Nutrients

  3. Flavonoids improve cognitive function.

    “flavonoids could improve cognitive function through the gut-brain axis.”

    Review

    Targeting gut-brain axis by dietary flavonoids ameliorate aging-related cognition decline: Evidences and mechanisms

    Critical reviews in food science and nutrition

  4. Flavonoids improve cognitive function in humans (g = 0.148, p < 0.001).

    “dietary flavonoids induced significant benefit to cognitive performance (g = 0.148, p < 0.001)”

    Reviewn = 5,519

    Dietary Flavonoids and Human Cognition: A Meta-Analysis

    Molecular nutrition & food research

Cellular senescence

downin reviews3

3 studies
  1. Flavonoids inhibit cellular senescence.

    “flavonoids which are found in many fruits are potential antisenescence factors that benefit health by reducing damage to DNA and the senescence-associated phenotypic cell changes in healthy cells during aging”

    Review

    Dietary flavonoid actions on senescence, aging, and applications for health

    The Journal of nutritional biochemistry

  2. Flavonoids decrease cellular senescence.

    “Naringenin, hesperetin, hesperidin, quercetin, fisetin, kaempferol, rutin, apigenin, luteolin, nobiletin, tangeretin, genistein, wogonin, epigallocatechin gallate (EGCG), theaflavin-3-gallate (TF2A), and procyanidin C1 possess potent antisenescence effects.”

    Review

    Potential Role of Polyphenolic Flavonoids as Senotherapeutic Agents in Degenerative Diseases and Geroprotection

    Pharmaceutical medicine

  3. Flavonoids inhibit cellular senescence.

    “eliminating senescent cells, inhibiting senescence-related secretion phenotypes (SASPs)”

    Review

    Flavonoids-Natural Gifts to Promote Health and Longevity

    International journal of molecular sciences

More on Cellular senescence

Neurodegenerative disease

downin reviews3

3 studies
  1. Flavonoids protect against neurodegenerative disease.

    “flavonoids and curcuminoids stand out for their extensively documented antioxidant, antiplatelet, and neuroprotective properties”

    Review

    The Effects of Fisetin and Curcumin on Oxidative Damage Caused by Transition Metals in Neurodegenerative Diseases

    Molecular neurobiology

  2. Flavonoids protect against neurodegenerative disease.

    “specifically emphasizing the promising role of flavonoids in mitigating NDD-related complications.”

    Review

    Unveiling the interplay of AMPK/SIRT1/PGC-1α axis in brain health: Promising targets against aging and NDDs

    Ageing research reviews

  3. Flavonoids protect against neurodegenerative disease.

    “the regulatory role of flavonoids in managing various NDDs has been shown to pass through AMPK/PGC-1α signaling pathway”

    Review

    Flavonoids modulate AMPK/PGC-1α and interconnected pathways toward potential neuroprotective activities

    Metabolic brain disease

More on Neurodegenerative disease

Cardiovascular disease

no changein humans1downin reviews1

2 studies
  1. Flavonoids were not clearly linked with cardiovascular disease in humans following atherosclerosis diagnosis.

    “Conversely, total flavonoid intake showed no significant association with cardiovascular disease risk or all-cause mortality following atherosclerosis diagnosis.”

    Humansfollowing atherosclerosis diagnosisn = 207,571

    Association of dietary flavonoid intake with incident atherosclerosis: cohort evidence in middle-aged and older adults

    Frontiers in nutrition

  2. Flavonoids protect against cardiovascular disease.

    “flavonoids, widely presented in fruits and vegetables worldwide, can delay or treat CVD via selectively eliminating SCs (senolytics) and modulating SASPs (senomorphics).”

    Review

    The potential of flavonoids to mitigate cellular senescence in cardiovascular disease

    Biogerontology

More on Cardiovascular disease

Lifespan

upin cells1upin invertebrates1

2 studies
  1. Flavonoids extend lifespan in vitro.

    “The biological activity assay revealed that most flavonoids exhibited significant antioxidant and lifespan-extending activities.”

    Cellsin vitro

    Herbacetin and gossypetin glycosides from Sedum kamtschaticum Fisch. & C. A. Mey. and S. takesimense Nakai, and their antioxidant, anti-aging, and monoamine oxidase inhibitory activities

    Phytochemistry

  2. Flavonoids extend lifespan in invertebrates.

    “worms and flies experienced lifespan extension when supplemented with flavonoids either as extracts or single compounds.”

    Review

    A literature review of flavonoids and lifespan in model organisms

    The Proceedings of the Nutrition Society

Bone mineral density

no changein humans1upin reviews1

2 studies
  1. Flavonoids were not clearly linked with bone mineral density in humans (nationally representative population).

    “Total flavonoid intakes were not significantly associated with BMD, BMC, or bone area of the femoral neck or lumbar spine in male or female participants.”

    Humansnationally representative populationn = 2,590

    Dietary Flavonoid and Subclass Intakes are not Associated with Markers of Bone Health in U.S. Adults Age 50+ Years

    Journal of the American Nutrition Association

  2. Flavonoids improve bone mineral density (osteoporosis or ovariectomy).

    “Most of them increase bone mineral density and bone strength”

    Reviewosteoporosis or ovariectomybonefemales

    Analysis of the Molecular Mechanisms by Flavonoids with Potential Use for Osteoporosis Prevention or Therapy

    Current medicinal chemistry

More on Bone mineral density

Muscle strength

upin humans1no changein humans1

2 studies
  1. Flavonoids improve muscle strength in adults with sarcopenia, across included RCTs (significant in two of six RCTs).

    “muscle strength significantly elevated in two studies”

    Reviewin adults with sarcopenia, across included RCTs

    The Effects of Flavonoids on Skeletal Muscle Mass, Muscle Function, and Physical Performance in Individuals with Sarcopenia: A Systematic Review of Randomized Controlled Trials

    Nutrients

  2. Flavonoids showed no clear effect on muscle strength in humans.

    “However, there was no significant improvement in the subjects' muscle strength.”

    Review

    Effect of flavonoids on skeletal muscle mass, strength and physical performance in middle-aged and older adults with or without Sarcopenia: A meta-analysis of randomized controlled trials

    Frontiers in nutrition

Mortality

downin humans1HR 0.8

1 study
  1. Flavonoids are linked with lower mortality in CKM stages 3 to 4 (Q4 vs Q1) (HR 0.80, 95% CI 0.65-0.99).

    “all-cause mortality in stages 3 to 4 (HR = 0.80; 95% CI: 0.65-0.99)”

    Humansin CKM stages 3 to 4 (Q4 vs Q1)

    Dietary flavonoids link to lower mortality across CKM stages

    Medicine

IGF-1

no changein humans1

1 study
  1. Flavonoids showed no clear effect on IGF-1 in humans (pooled clinical studies, meta-analysis).

    “The results showed that the effect of flavonoids on changes in IGF1 and IGFBP-3 was not statistically significant.”

    Human trialpooled clinical studies, meta-analysis

    A Systematic Review and Meta-Analysis on the Effect of Flavonoids on Insulin-like Growth Factor and Insulin-like Growth Factor Binding Protein and Incidence of Breast Cancer

    Current medicinal chemistry

More on IGF-1

All 52

What is flavonoids linked with?

31

Studies link flavonoids with 31 measures, among them Parkinson's disease, mortality and frailty.

Parkinson's disease

downin humans2HR 0.75

2 studies
  1. Flavonoids are linked with a lower risk of Parkinson's disease in humans (highest vs lowest quartile) (HR 0.75, 95% CI 0.61-0.93).

    “the risk was lower in the highest than in the lowest FDS quartile (HR, 0.75; 95% CI, 0.61-0.93)”

    Humanshighest vs lowest quartile

    Flavonoid-rich dietary patterns and incident hospital-recorded Parkinson's disease: a prospective UK Biobank study

    Frontiers in nutrition

  2. Flavonoids lower the risk of Parkinson's disease in humans.

    “The consumption of flavonoids, anthocyanins, or 2-5 servings/week of specific foods (apples, red wine, blueberries, and strawberries) reduces the risk of PD and associated mortality.”

    Review

    Dietary flavonoids may have a protective and therapeutic effect in Parkinson disease: A systematic review

    Nutrition research (New York, N.Y.)

More on Parkinson's disease

Mortality

downin humans2

2 studies
  1. Flavonoids are linked with a lower risk of mortality in humans (optimal intake levels ranging from 48.93 mg to 735.65 mg).

    “Analysis found a U-shaped correlation between dietary flavonoid consumption and ACM, with optimal intake levels ranging from 48.93 mg to 735.65 mg.”

    Humans121 months

    Dietary flavonoid intake is linked to reduced all-cause mortality: Findings from the National Health and Nutrition Examination Survey (NHANES)

    Pakistan journal of medical sciences

  2. Flavonoids are linked with a lower risk of mortality in humans (comparing the highest and lowest quintiles) (hazard ratios: 0.87-0.94).

    “total dietary flavonoids and most flavonoid subclasses were related to significantly lower total mortality (hazard ratios: 0.87-0.94), comparing the highest and lowest quintiles.”

    Humanscomparing the highest and lowest quintilesmedian follow-up of 23.5 yearsn = 369,827

    Associations of dietary flavonoids and subclasses with total and cardiovascular mortality among 369,827 older people: The NIH-AARP Diet and Health Study

    Atherosclerosis

Frailty

downin humans2OR 0.68–0.79

2 studies
  1. Flavonoids are linked with a lower risk of frailty in humans (highest vs lowest tertile of intake; adults with prediabetes or diabetes) (OR 0.68 (95% CI 0.48-0.96), 32% lower risk).

    “exhibited a 32% (odds ratio [OR] = 0.68, 95% confidence interval [CI]: 0.48-0.96) lower risk of frailty”

    Humanshighest vs lowest tertile of intake; adults with prediabetes or diabetes

    Dietary flavonoid intake and frailty in middle-aged and older U.S. adults with prediabetes or diabetes: A population-based study

    Medicine

  2. Flavonoids are linked with a lower risk of frailty in humans (OR: 0.79, 95% CI: 0.65-0.95).

    “Higher intakes of total flavonoids (OR:0.79, 95% CI:0.65-0.95), anthocyanidins (OR:0.71, 95% CI:0.58-0.88), flavanones (OR:0.74, 95% CI:0.59-0.92), flavones (OR:0.76, 95% CI:0.59-0.97), and flavonols (OR:0.67, 95% CI:0.56-0.81) were significantly associated with lower prevalence of frailty”

    Humansn = 12,152

    Inverse associations between dietary flavonoid and subclass intakes and frailty in U.S. adults

    Frontiers in nutrition

Advanced cardiovascular-kidney-metabolic syndrome stages

downin humans1

1 study
  1. Flavonoids are associated with advanced cardiovascular-kidney-metabolic syndrome stages in humans (Lowest observed risk estimated at 449 mg/d).

    “Higher total flavonoids, flavonols and quercetin intake was associated with lower odds of advanced CKM stage.”

    Humans

    Quercetin Intake and CKM Syndrome Risk: Dose-Response and Mechanistic Insights

    Research SquarePreprint

More on Advanced cardiovascular-kidney-metabolic syndrome stages

Cardiovascular-kidney-metabolic syndrome

downin humans1OR 0.53

1 study
  1. Flavonoids are linked with a lower risk of cardiovascular-kidney-metabolic syndrome in humans (stage 2 vs 0 (Q4 vs Q1)) (OR 0.53, 95% CI 0.33-0.83).

    “Higher flavonoid intake was associated with lower odds of advanced CKM stage (stage 2 vs 0: Q4 odds ratio: 0.53; 95% confidence interval [CI]: 0.33-0.83).”

    Humansstage 2 vs 0 (Q4 vs Q1)

    Dietary flavonoids link to lower mortality across CKM stages

    Medicine

More on Cardiovascular-kidney-metabolic syndrome

Atherosclerotic cardiovascular disease

downin humans1HR 0.923

1 study
  1. Flavonoids are linked with a lower risk of atherosclerotic cardiovascular disease in humans (highest quartile versus lowest quartile) (HR = 0.923, 95% CI: 0.853–0.998).

    “Participants in the highest quartile of total flavonoid intake had a modestly lower risk of ASCVD than those in the lowest quartile (HR = 0.923, 95% CI: 0.853–0.998).”

    Humanshighest quartile versus lowest quartile

    Total Flavonoid Intake, Plasma atherosclerosis index, and Risk of Incident ASCVD: A Prospective Cohort Study from the UK Biobank

    Research SquarePreprint

More on Atherosclerotic cardiovascular disease

Neurodegenerative disease

downin humans1OR 0.52

1 study
  1. Flavonoids are linked with a lower risk of neurodegenerative disease in humans (OR = 0.52, 95% CI: 0.31-0.90).

    “higher total flavonoid intake was associated with lower odds of NDs after adjustment for demographic, socioeconomic, lifestyle, and clinical covariates (Q4 vs. Q1: OR = 0.52, 95% CI: 0.31-0.90).”

    Humansn = 13,573

    The Associations Between Dietary Flavonoid Intake and Neurodegenerative Diseases Risk: A Cross-Sectional Study

    Chemical biology & drug design

More on Neurodegenerative disease

Hepatic steatosis

downin humans1−40% reduced odds

1 study
  1. Flavonoids are linked with a lower risk of hepatic steatosis in humans (before adjustment for diet quality) (up to 40 % reduced odds).

    “Higher intake of flavonols, flavan-3-ols, anthocyanidins, flavonoid polymers and total flavonoids is associated with lower odds of hepatic steatosis (Ptrend < 0·05)”

    Humansbefore adjustment for diet quality

    Diet quality attenuates the association between flavonoid intake and hepatic steatosis risk in the Framingham Heart Study

    The British journal of nutrition

More on Hepatic steatosis

Adiposity

downin humans1

1 study
  1. Flavonoids are associated with adiposity in humans (betalog2 -0.54% (95% CI -0.70; -0.40)).

    “Doubling in total flavonoid intake was inversely associated with BF [betalog2 -0.54% (95% CI -0.70; -0.40)]”

    Humansn = 11,568

    Associations between dietary intake of flavonoids and adiposity: cross-sectional findings from the Fenland Study, the United Kingdom

    International journal of obesity (2005)

Atherosclerosis

downin humans1HR 0.781

1 study
  1. Flavonoids are linked with a lower risk of atherosclerosis in humans (HR = 0.781, 95% CI: 0.634-0.961).

    “participants in the highest quartile (Q4) of total flavonoid intake exhibited a significantly lower risk of atherosclerosis compared to those in the lowest quartile (Q1) (HR = 0.781, 95% CI: 0.634-0.961, p = 0.020).”

    Humansn = 207,571

    Association of dietary flavonoid intake with incident atherosclerosis: cohort evidence in middle-aged and older adults

    Frontiers in nutrition

More on Atherosclerosis

All 31

Funding

2 grants since 2020

Japan Society for the Promotion of Science¥17.9MBiotechnology and Biological Sciences Research Council

Contains public sector information licensed under the Open Government Licence v3.0.

How this record changed

  1. Summary rewritten as its findings changed.

    As it read before

    One human study links flavonoids to lower cancer mortality in cardiovascular-kidney-metabolic syndrome stages 1–2, lower mortality in stages 3–4, and lower odds of stage 2 versus stage 0, comparing highest with lowest quartiles.

  2. Summary written from the findings.

Latest

Dec 2025: 4Jan 2026: 11Feb 2026: 9Mar 2026: 10Apr 2026: 4May 2026: 1Jun 2026: 6Jul 2026: 7Aug 2026: 6Sep 2026: 5Oct 2026: 4Nov 2026: 168 papers in 12 months
Medicine

Dietary flavonoids link to lower mortality across CKM stages

Top-quartile flavonoid intake lowered odds of stage 2 CKM syndrome to an odds ratio of 0.53 versus stage 0 among 10,754 US adults.Top-quartile flavonoid intake lowered odds of stage 2 CKM syndrome to an odds ratio of 0.53 versus stage 0 among 10,754 US adults.

Cohort study of 10,754 peoplePopulations

See all 176 papers on flavonoids